Skip to contentS
Skinvisible, Inc.
S
SKVISkinvisible, Inc. Q2 2026 · 10-Q
Revenue$5.00K$5.00K±0.0% vs Q2 2025 Net Income-$255.53K-$255.53KN/M vs Q2 2025 EPS, diluted—
Operating Income-$112,817N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Skinvisible, Inc. · CIK 1085277 · Engraved from SEC EDGAR
Operating Cash Flowderived$2,161N/M Margins · derivedGross margin100.0%±0.0 pt vs Q2 2025
Operating margin-2256.3%+468.4 pt vs Q2 2025
Net margin-5110.7%+377.9 pt vs Q2 2025
ended Jun 30, 2026 · filed Aug 13, 2026 · 44 d after period end